Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

Inclusion Criteria * Mild intermittent asthma (meeting GINA specifications - www.ginasthma.com) * Medically normal subjects with no significant abnormal findings * No tobacco (nicotine products) use for at least 2 years before the study starts * Normal (or abnormal and clinically insignificant) laboratory values at screening (potassium or glucose levels) * No significant medical or surgical conditions (COPD, cystic fibrosis, severe allergic rhinitis) Exclusion Criteria: * Past or present history of experiencing any allergic reaction to the medications/formulations administered in this study, or in the opinion of the Principal Investigator, suggests an increased potential for an adverse hypersensitivity * Subject with abnormal screening visit vital signs or clinical laboratory evaluation considered clinically significant by the Principal Investigator